Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Controlled Substances Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Controlled Substances Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Controlled Substances Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Opioids
    • 1.4.3 Stimulants
    • 1.4.4 Depressants
    • 1.4.5 Marijuana
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Controlled Substances Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Controlled Substances Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Controlled Substances Industry
      • 1.6.1.1 Controlled Substances Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Controlled Substances Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Controlled Substances Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Controlled Substances Market Perspective (2015-2026)
  • 2.2 Controlled Substances Growth Trends by Regions
    • 2.2.1 Controlled Substances Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Controlled Substances Historic Market Share by Regions (2015-2020)
    • 2.2.3 Controlled Substances Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Controlled Substances Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Controlled Substances Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Controlled Substances Players by Market Size
    • 3.1.1 Global Top Controlled Substances Players by Revenue (2015-2020)
    • 3.1.2 Global Controlled Substances Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Controlled Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Controlled Substances Market Concentration Ratio
    • 3.2.1 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Controlled Substances Revenue in 2019
  • 3.3 Controlled Substances Key Players Head office and Area Served
  • 3.4 Key Players Controlled Substances Product Solution and Service
  • 3.5 Date of Enter into Controlled Substances Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Controlled Substances Historic Market Size by Type (2015-2020)
  • 4.2 Global Controlled Substances Forecasted Market Size by Type (2021-2026)

5 Controlled Substances Breakdown Data by Application (2015-2026)

  • 5.1 Global Controlled Substances Market Size by Application (2015-2020)
  • 5.2 Global Controlled Substances Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Controlled Substances Market Size (2015-2020)
  • 6.2 Controlled Substances Key Players in North America (2019-2020)
  • 6.3 North America Controlled Substances Market Size by Type (2015-2020)
  • 6.4 North America Controlled Substances Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Controlled Substances Market Size (2015-2020)
  • 7.2 Controlled Substances Key Players in Europe (2019-2020)
  • 7.3 Europe Controlled Substances Market Size by Type (2015-2020)
  • 7.4 Europe Controlled Substances Market Size by Application (2015-2020)

8 China

  • 8.1 China Controlled Substances Market Size (2015-2020)
  • 8.2 Controlled Substances Key Players in China (2019-2020)
  • 8.3 China Controlled Substances Market Size by Type (2015-2020)
  • 8.4 China Controlled Substances Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Controlled Substances Market Size (2015-2020)
  • 9.2 Controlled Substances Key Players in Japan (2019-2020)
  • 9.3 Japan Controlled Substances Market Size by Type (2015-2020)
  • 9.4 Japan Controlled Substances Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Controlled Substances Market Size (2015-2020)
  • 10.2 Controlled Substances Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Controlled Substances Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Controlled Substances Market Size by Application (2015-2020)

11 India

  • 11.1 India Controlled Substances Market Size (2015-2020)
  • 11.2 Controlled Substances Key Players in India (2019-2020)
  • 11.3 India Controlled Substances Market Size by Type (2015-2020)
  • 11.4 India Controlled Substances Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Controlled Substances Market Size (2015-2020)
  • 12.2 Controlled Substances Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Controlled Substances Market Size by Type (2015-2020)
  • 12.4 Central & South America Controlled Substances Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Johnson & Johnson
    • 13.1.1 Johnson & Johnson Company Details
    • 13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.1.3 Johnson & Johnson Controlled Substances Introduction
    • 13.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2015-2020))
    • 13.1.5 Johnson & Johnson Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview and Its Total Revenue
    • 13.2.3 Pfizer Controlled Substances Introduction
    • 13.2.4 Pfizer Revenue in Controlled Substances Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Siegfried AG
    • 13.3.1 Siegfried AG Company Details
    • 13.3.2 Siegfried AG Business Overview and Its Total Revenue
    • 13.3.3 Siegfried AG Controlled Substances Introduction
    • 13.3.4 Siegfried AG Revenue in Controlled Substances Business (2015-2020)
    • 13.3.5 Siegfried AG Recent Development
  • 13.4 GlaxoSmithKline
    • 13.4.1 GlaxoSmithKline Company Details
    • 13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.4.3 GlaxoSmithKline Controlled Substances Introduction
    • 13.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2015-2020)
    • 13.4.5 GlaxoSmithKline Recent Development
  • 13.5 Teva Pharmaceuticals
    • 13.5.1 Teva Pharmaceuticals Company Details
    • 13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
    • 13.5.3 Teva Pharmaceuticals Controlled Substances Introduction
    • 13.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2015-2020)
    • 13.5.5 Teva Pharmaceuticals Recent Development
  • 13.6 Mylan
    • 13.6.1 Mylan Company Details
    • 13.6.2 Mylan Business Overview and Its Total Revenue
    • 13.6.3 Mylan Controlled Substances Introduction
    • 13.6.4 Mylan Revenue in Controlled Substances Business (2015-2020)
    • 13.6.5 Mylan Recent Development
  • 13.7 Takeda Pharmaceutical
    • 13.7.1 Takeda Pharmaceutical Company Details
    • 13.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
    • 13.7.3 Takeda Pharmaceutical Controlled Substances Introduction
    • 13.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
    • 13.7.5 Takeda Pharmaceutical Recent Development
  • 13.8 Sun Pharmaceutical
    • 13.8.1 Sun Pharmaceutical Company Details
    • 13.8.2 Sun Pharmaceutical Business Overview and Its Total Revenue
    • 13.8.3 Sun Pharmaceutical Controlled Substances Introduction
    • 13.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2015-2020)
    • 13.8.5 Sun Pharmaceutical Recent Development
  • 13.9 Daiichi Sankyo
    • 13.9.1 Daiichi Sankyo Company Details
    • 13.9.2 Daiichi Sankyo Business Overview and Its Total Revenue
    • 13.9.3 Daiichi Sankyo Controlled Substances Introduction
    • 13.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2015-2020)
    • 13.9.5 Daiichi Sankyo Recent Development
  • 13.10 Akorn Inc
    • 13.10.1 Akorn Inc Company Details
    • 13.10.2 Akorn Inc Business Overview and Its Total Revenue
    • 13.10.3 Akorn Inc Controlled Substances Introduction
    • 13.10.4 Akorn Inc Revenue in Controlled Substances Business (2015-2020)
    • 13.10.5 Akorn Inc Recent Development
  • 13.11 Tilray
    • 10.11.1 Tilray Company Details
    • 10.11.2 Tilray Business Overview and Its Total Revenue
    • 10.11.3 Tilray Controlled Substances Introduction
    • 10.11.4 Tilray Revenue in Controlled Substances Business (2015-2020)
    • 10.11.5 Tilray Recent Development
  • 13.12 Medical Marijuana, Inc
    • 10.12.1 Medical Marijuana, Inc Company Details
    • 10.12.2 Medical Marijuana, Inc Business Overview and Its Total Revenue
    • 10.12.3 Medical Marijuana, Inc Controlled Substances Introduction
    • 10.12.4 Medical Marijuana, Inc Revenue in Controlled Substances Business (2015-2020)
    • 10.12.5 Medical Marijuana, Inc Recent Development
  • 13.13 Consort Medical
    • 10.13.1 Consort Medical Company Details
    • 10.13.2 Consort Medical Business Overview and Its Total Revenue
    • 10.13.3 Consort Medical Controlled Substances Introduction
    • 10.13.4 Consort Medical Revenue in Controlled Substances Business (2015-2020)
    • 10.13.5 Consort Medical Recent Development
  • 13.14 Purdue Pharma
    • 10.14.1 Purdue Pharma Company Details
    • 10.14.2 Purdue Pharma Business Overview and Its Total Revenue
    • 10.14.3 Purdue Pharma Controlled Substances Introduction
    • 10.14.4 Purdue Pharma Revenue in Controlled Substances Business (2015-2020)
    • 10.14.5 Purdue Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Controlled Substances status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Controlled Substances development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Johnson & Johnson
    Pfizer
    Siegfried AG
    GlaxoSmithKline
    Teva Pharmaceuticals
    Mylan
    Takeda Pharmaceutical
    Sun Pharmaceutical
    Daiichi Sankyo
    Akorn Inc
    Tilray
    Medical Marijuana, Inc
    Consort Medical
    Purdue Pharma

    Market segment by Type, the product can be split into
    Opioids
    Stimulants
    Depressants
    Marijuana
    Others
    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Controlled Substances status, future forecast, growth opportunity, key market and key players.
    To present the Controlled Substances development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Controlled Substances are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now